N2-(tert-Butoxycarbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)-D-lysine

Catalog No. :
ACOGBX108
CAS No. :
1301706-85-3
Molecular Formula :
C24H40N2O6
Molecular Weight :
452.59

IUPAC Name:N2-(tert-butoxycarbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)-D-lysine

N2-(tert-Butoxycarbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)-D-lysine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN2-(tert-Butoxycarbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)-D-lysine
IUPAC NameN2-(tert-butoxycarbonyl)-N6-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl)-D-lysine
Molecular FormulaC24H40N2O6
Molecular Weight452.59
SMILESC(NCCCC[C@@H](NC(OC(C)(C)C)=O)C(O)=O)(CC(C)C)=C1C(=O)CC(C)(C)CC1=O
InChI KeyQNYLJYLZSXQBRR-MRXNPFEDSA-N
SynonymBoc-D-Lys(ivDde)-OH;N-alpha-t-Butyloxycarbonyl-N-epsilon-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-D-lysine;(2R)-6-[[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)-3-methylbutylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid;D-Lysine, N6-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]-N2-[(1,1-dimethylethoxy)carbonyl]-
CAS No.1301706-85-3

Synthetic Route by SureRoute

1. ACOGBX108 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOLD047 route compound structure diagram
    ACPOLD047126-81-8 In Stock
  4. Then
  5. ACOGBX108 route product structure diagram
    ACOGBX1081301706-85-3
Inquiry

2. ACOGBX108 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOGBX108 route product structure diagram
    ACOGBX1081301706-85-3
Inquiry

Comments (0)